Activity of erythrocyte sodium-hydrogen exchange in normal pregnancy.
1. Pregnancy is associated with a 30-50% rise in cardiac output and a 50% increase in blood volume. The contribution of changes in the activity of primary and secondary active transporters to these haemodynamic adaptations remains unknown. For the first time, we measured sodium-hydrogen exchange activity over the course of normal pregnancy. 2. Eighteen healthy pregnant women were studied at 14, 24 and 33 weeks of gestation and compared with 18 non-pregnant healthy women. None of the pregnancies was complicated by hypertension. At each antenatal visit, body weight and blood pressure were recorded, blood and 24 h-urine samples were taken to control renal function and metabolic equilibrium, maternal glucose tolerance was evaluated by oral glucose test and glycated haemoglobin testing, and erythrocyte sodium-hydrogen antiport was also measured. 3. Erythrocyte antiport activity values were 10.0 +/- 3.0, 9.6 +/- 2.9 and 8.4 +/- 3.5 mmol h-1 (litre of cells)-1 in the three gestational trimesters respectively, significantly higher at each trimester than in control women [6.8 +/- 2.5 mmol h-1 (litre of cells)-1]. The clearances of urea and creatinine were constantly elevated in pregnant women; at each trimester their serum concentrations were lower than in non-pregnant women. Serum potassium significantly decreased during pregnancy. Serum total cholesterol and triacylglycerol levels, already above the normal range from the first trimester, further increased until the third trimester. The area under the glycaemic curve became larger during pregnancy, and the area under the insulinaemic curve increased to a lesser extent. There was a significant association between antiport activity and serum triacylglycerol levels. 4. The observed hyperactivity of the transporter, peaking at the fourteenth week of gestation, may be a contributing factor to the haemodynamic adjustments attending upon normal pregnancy.
Matteucci
E
E
Istituto di Clinica Medica II, Università di Pisa, Italy.
Giampietro
O
O
D000328:Adult; D019540:Area Under Curve; D001786:Blood Glucose / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D003404:Creatinine / Q000378:metabolism; D004912:Erythrocytes / Q000378:metabolism*; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood; D011188:Potassium / Q000097:blood; D011247:Pregnancy / Q000378:metabolism*; D017923:Sodium-Hydrogen Exchangers / Q000378:metabolism*; D014280:Triglycerides / Q000097:blood; D014508:Urea / Q000378:metabolism
D001786:Blood Glucose; D007328:Insulin; D017923:Sodium-Hydrogen Exchangers; D014280:Triglycerides; D014508:Urea; D002784:Cholesterol; D003404:Creatinine; D011188:Potassium